Physician profile
Una Shah
NPI 1699959213
$825.01
in general payments reported to CMS, 2019-2025
13 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.18 · 2021: $60.11 · 2022: $59.80 · 2023: $193 · 2024: $289 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577 · Education: $45.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.11 |
| Education | $45.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $126.45 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $121.83 | 2024 | Farxiga |
| Novo Nordisk INC | $121.77 | 2024 | |
| Sun Pharmaceutical Industries INC. | $108.65 | 2021-2023 | Ilumya, Odomzo, Blu-U |
| Axonics, INC. | $68.77 | 2023 | Axonics |
| Pfizer INC. | $61.11 | 2022-2024 | |
| Abbvie INC. | $43.91 | 2019-2021 | |
| Genzyme Corporation | $41.83 | 2019-2023 | |
| Dusa Pharmaceuticals, INC. | $34.32 | 2019 | |
| Dermavant Sciences, INC. | $29.68 | 2023 | Vtama |
| Allergan, INC. | $29.27 | 2021 | |
| Janssen Biotech, INC. | $23.38 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Una Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.